For instance, miR-124-3p.1 sensitizes the response of HCC cells to sorafenib by regulating FOXO3a levels through targeting AKT2 and SIRT1 [20], and miR-221-3p targets LIFR to regulates HCC cell performance [21]. Here, LIFR is linked to hepatocellular carcinoma.